Syngene gets nod to raise foreign investment to 44%
Syngene, a subsidiary of Biocon, on Monday said it has received the Foreign Investment Promotion Board (FIPB) approval for raising foreign investment in the company to 44 percent from the earlier approved 10 percent.
Jun 22, 2015, 15:27 PM IST
Govt approves FDI worth Rs 4,000 cr in pharma sector
Proposals for foreign direct investment amounting to around Rs 4,000 crore by four pharma and medical devices firms, including Torrent Pharmaceuticals and Biocon's research services arm Syngene, were on Wednesday approved by the government.
Jun 17, 2015, 17:15 PM IST
Biocon files IPO prospectus for R&D arm Syngene
Biotech firm Biocon Ltd has filed a prospectus for the initial public offering of its USD 600 million research and development arm, Syngene, it said on Thursday.
Apr 23, 2015, 10:07 AM IST
Biocon files prospectus for Syngene IPO to raise Rs 600 cr
Biotechnology major Biocon Wednesday filed prospectus with market regulator SEBI for the initial public offer of its research arm Syngene through which aims to raise around Rs 600 crore that will be used to fund its R&D programmes.
Apr 22, 2015, 20:00 PM IST
Biocon arm Syngene appoints Peter Bains as CEO
Biotechnology major Biocon's custom research arm Syngene has appointed Peter Bains as its Chief executive Officer (CEO).
Apr 01, 2015, 18:09 PM IST
Biocon says to take Syngene unit public
Biocon Ltd will list its research services business arm Syngene by selling up to 15 percent stake in a public offer, the company said, after reporting third-quarter earnings.
Jan 23, 2015, 09:06 AM IST
Biocon completes 10% stake sale in Syngene
Biotechnology major Biocon on Monday concluded sale of 10 percent stake in its research arm Syngene for Rs 380 crore to IVF Trustee Company Private Ltd.
Jan 12, 2015, 19:26 PM IST
